Rezolute, Inc.

RZLT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $10.6M $11.2M $11.9M $9.1M $94.1M $14.6M $8.9M $10.5M
Accounts Receivable — — — — — — — —
Inventory — — — — — — — —
Total Current Assets $110.5M $122.0M $135.1M $154.7M $171.1M $88.7M $98.7M $110.2M
Property, Plant & Equipment $41.0K $49.0K $57.0K $64.0K $72.0K $80.0K $87.0K $95.0K
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $112.8M $125.5M $138.6M $158.7M $175.5M $94.7M $112.0M $123.4M
Liabilities
Accounts Payable $5.0M $3.2M $3.8M $3.3M $5.8M $6.5M $3.1M $2.2M
Total Current Liabilities $11.4M $7.7M $9.5M $10.2M $11.9M $10.5M $10.6M $8.0M
Long-Term Debt — — — — — — — —
Total Liabilities $12.2M $8.6M $10.6M $11.5M $13.4M $12.2M $12.4M $10.0M
Stockholders' Equity
Retained Earnings $-481.4M $-461.0M $-444.8M $-422.0M $-403.9M $-379.5M $-360.6M $-344.8M
Total Stockholders' Equity $100.7M $116.8M $128.0M $147.2M $162.1M $82.6M $99.6M $113.4M
← Newer Page 1 of 8 Older →